Intellectual Property

Ablitech has filed for the protection of two platform technologies for drug delivery.  This includes one full patent application and one

provisional patent application (as listed below).  Ablitech is currently focused on the expansion and development of these two

technologies.

Patents

Monomers and Polymers with Covalently-Attached Active Ingredients. Kemp, L., Hammond, N.

U.S. Pat. Appl. (2009), US 2009033804.

Covalently Modified Biological Molecules And The Biologically Active Agents Generated For

Delivery And Targeting. Kemp, L., Hammond, N., Hodges, T. U.S. Pat. Prov. (2009).